DataSheet1_SYDE1 Acts as an Oncogene in Glioma and has Diagnostic and Prognostic Values.docx (1.6 MB)
Download file

DataSheet1_SYDE1 Acts as an Oncogene in Glioma and has Diagnostic and Prognostic Values.docx

Download (1.6 MB)
dataset
posted on 14.10.2021, 05:17 by Zhenyuan Han, Xiaodong Zhuang, Biao Yang, Lihui Jin, Pengjie Hong, Junqing Xue, Shunjie Chen, Zhen Tian

Objectives: Gliomas remain one of serious public health problems worldwide which demand further and deeper investigation. The aim of this study was to explore the association between synapse defective protein 1 homolog 1 (SYDE1) and gliomas via public database analysis and in vitro validation to determine the potential diagnostic and prognostic values.

Methods and Results: Compared with healthy brain tissues, there was a significant increase in SYDE1 expression in glioma tissues. Additionally, SYDE1 exhibited higher expression levels in glioma patients with unfavorable clinicopathological factors. In vitro knockdown of SYDE1 in glioma cell lines A172 inhibited their migrative and invasive ability but not the proliferative ability. GO and KEGG pathway analysis of the top 100 genes coexpressed with SYDE1 showed enrichments of tumor-associated terms. Further bioinformatic analysis revealed that the SNHG16/hsa-miR-520e/SYDE1 axis might be involved in glioma development.

Conclusions:SYDE1 is expressed at higher levels in gliomas than in healthy brains, and can promote metastasis and invasion but not proliferation of gliomas. Furthermore, SYDE1 has values in the diagnosis and prognosis prediction of gliomas.

History